A faster way to identify brain tumors in children
Original title: Concordance of rapid whole genome and targeted long read sequencing of pediatric brain tumors with standard clinical testing.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
It was checked on real tumor samples, but it is not standard care yet.
The short version
A single gene test matched standard lab tests in most child brain tumor samples.
What was studied. Researchers tested 23 brain tumor samples from children, covering 10 tumor types. They compared a new single gene test to standard lab testing.
What they found. The new test found 42 of 51 known gene changes. It also found 5 of 6 known gene fusions. It matched the clinical diagnosis in 20 of 22 tumors.
What this means, and what it doesn't
What it could mean: Today, full tumor testing can take weeks or months. This test may give answers much faster, sometimes within an hour. It also uses less tumor tissue. Faster answers could help doctors plan care sooner.
What it doesn't mean: This is not a treatment, and it is not a cure. It is a lab test, checked against testing already in use. It was tried on a small number of samples. It is not part of everyday care yet. More work is needed before most hospitals can use it.
Source: PubMed, September 2, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.